Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05691738
Other study ID # KMU-ACEYLAN-001
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date October 3, 2022
Est. completion date December 31, 2023

Study information

Verified date January 2024
Source Karamanoglu Mehmetbey University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of the study is to investigate the effects of modified otago exercises on joint position sense, balance and physical fitness parameters in individuals with diabetic neuropathy. In addition aim of to examine the effects of exercise on metabolic variables and to gain exercise awareness in diabetic individuals.


Recruitment information / eligibility

Status Completed
Enrollment 38
Est. completion date December 31, 2023
Est. primary completion date December 31, 2023
Accepts healthy volunteers No
Gender All
Age group 40 Years to 65 Years
Eligibility Inclusion Criteria: - Individuals with Neuropathy Diagnosed with Type 2 Diabetes between the Ages of 40-65 Years - Cooperative, able to take instructions (Mini Mental Test score of 24 and above) - Able to walk independently - With a Body Mass Index Below 40 Kg/M2 - Not Doing Regular Physical Activity for the Last 6 Months - Voluntarily participated in the research Exclusion Criteria: - Additional neurological problem other than neuropathy - Any orthopedic or systemic problems that will prevent him from performing the exercises - The presence of pathology related to the lower limb that occurred within the last 6 months (surgery, fracture, soft tissue injuries, etc.) - Pregnant - Vision problem that cannot be corrected with glasses or lenses - Hearing loss that cannot be corrected with hearing aids - Foot ulcer - Patients who have been diagnosed with cancer and are receiving chemotherapy in this context - With limitation of the range of motion of the joints of the lower extremities

Study Design


Intervention

Other:
Exercise Group
The exercise group will be informed about diabetes and diabetes complications. A total of 16 sessions of 8 weeks, modified otago exercises will be applied individually by the research physiotherapist.Individuals will be allowed to walk at a moderate pace for at least 30 minutes 5 days a week (home program).
Control Group
The control group will be informed about diabetes and diabetes complications. Individuals will be allowed to walk at a moderate pace for at least 30 minutes 5 days a week (home program)

Locations

Country Name City State
Turkey Karaman Provincial Health Directorate Karaman Training and Research Hospital Karaman Center

Sponsors (2)

Lead Sponsor Collaborator
Karamanoglu Mehmetbey University Ankara Yildirim Beyazit University

Country where clinical trial is conducted

Turkey, 

Outcome

Type Measure Description Time frame Safety issue
Primary Blood Glucose Level Routinely, the glycated hemoglobin (Hba1c) (mg/dL) level will be recorded in the blood laboratory results by the endocrinologist. Change from baseline at 8 weeks
Primary Blood Cholesterol Level Routinely, the cholesterol (mg/dL) level will be recorded in the blood laboratory results by the endocrinologist. Change from baseline at 8 weeks
Primary Blood Triglycerides Level Routinely, the triglycerides (mg/dL) level will be recorded in the blood laboratory results by the endocrinologist. Change from baseline at 8 weeks
Primary Blood HDL Cholesterol Level Routinely, the HDL cholesterol (mg/dL) level will be recorded in the blood laboratory results by the endocrinologist. Change from baseline at 8 weeks
Primary Blood LDL Cholesterol Level Routinely, the LDL cholesterol (mg/dL) level will be recorded in the blood laboratory results by the endocrinologist. Change from baseline at 8 weeks
Primary Joint Position Sense Evaluation Target angles for knee joint joint position sense will be determined as 30 and 60 degrees of knee flexion. Ankle joint position sense of 10 degrees dorsiflexion and 15 degrees plantar flexion target angles will be evaluated. Change from baseline at 8 weeks
Primary The Timed Up & Go (Functional Mobility Assessment) Patients sitting in a chair without armrests will be asked to stand up with the start command and walk the 3-meter distance, whose start and end points are specified before, turn around and sit on the chair again. The test will be repeated 3 times and the average time will be recorded. Change from baseline at 8 weeks
Primary Balance Evaluation Balance Error Scoring System:Practices are performed on hard and soft ground separately in 3 positions, two feet, one foot and tandem stance, with eyes closed.After the test position is taught to the patient, the patient is asked to close their eyes and hold the position for 20 seconds.A mistake made for 20 seconds on each floor and position is recorded as 1 point.The maximum error score is 10.All assessments are made without shoes Change from baseline at 8 weeks
Primary Body Mass Index Evaluation Body weight of the individual is recorded in kilograms and height in meters.Calculated by dividing body weight by the square of the height in meters (kg/m2) Change from baseline at 8 weeks
Primary Body Weight Calculated in kilograms (kg) with a Tanita BC730 brand scale Change from baseline at 8 weeks
Primary Body Fat Percentage Body fat percentage is calculated as percentage (%) with Tanita BC730 brand scale Change from baseline at 8 weeks
Primary Lean Body Weight Calculated in kilograms (kg) by subtracting body fat from body weight. Change from baseline at 8 weeks
Primary Cardio-respiratory Fitness Evaluation A distance of 30 meters is created in an area measuring 10x40 meters, the start and end points are marked.Patients are asked to walk on the designated line for 6 minutes at the highest speed they can walk without running.At the end of 6 minutes, the distance they have walked is recorded in meters. Change from baseline at 8 weeks
Primary Sit and Reach Test (Flexibility ) Evaluation The patient is asked to lie down without bending his knees towards the ruler placed on the flexibility table. Before the test, the patient is asked to reach forward 1-2 times and is taught what to do. Then the patient is asked to lie forward 3 times and the average of the data obtained is recorded in centimeters. Change from baseline at 8 weeks
Primary Muscle Strength (30-second Chair Stand Test) Evaluation Sitting in a standard chair without armrests, the patient is asked to cross his hands over his shoulder. With the start command, the stopwatch is kept and the patient is asked to stand up completely from the chair and sit down again. The number of repetitive movements for 30 seconds is recorded. Change from baseline at 8 weeks
Primary Falling Risk Fall Efficacy Scale International: It is a common test battery with 16 items that reveals the possibility of falling in patients.The higher the test score, the higher the probability of falling in the patient. Change from baseline at 8 weeks
Secondary Cognitive Status Mini Mental Test will be used to evaluate the cognitive status of individuals. It is a short, useful, standardized test that provides the opportunity to evaluate cognitive performance in a short time. A high score indicates a good cognitive status. The maximum possible score is 30. A score of 17 and below is considered severe dementia, a score of 18-23 is considered mild dementia, and a score of 24-30 is considered normal. a day before the start of treatment
Secondary Neuropathic Pain Scale Self-Leeds Assesment of Neuropathic Symptoms & Signs Pain Score: It is a simple test used in the differential diagnosis of neuropathic pain at the bedside.A score of 12 and above is diagnostic for neuropathic pain Change from baseline at 8 weeks
Secondary Individual Exercise Intensity Borg Scale: It is a method used to determine the exercise tolerance of the individual.The individual scores the fatigue she feels between 6-20.Fatigue level; nothing (6), very very light (7-8), very light (9-10), light (11-12), somewhat difficult (13-14), difficult (15-16), very difficult (17- 18), very very difficult (19), exhaustion (20) a day before the start of treatment
Secondary Monofilament Evaluation The monofilament is touched to the relevant point on the foot until it takes a C shape. Absence of a 4.17 or thicker monofilament is interpreted as being compatible with neuropathy.Failure to detect a 5.07 monofilament is considered as a loss of protective sensation. a day before the start of treatment
Secondary Diaposan (Vibration) Evaluation A 128 Hz tuning fork, which was oscillated before, is placed on the metatarsophalangeal joint of both feet of the individual and the patient is asked to feel the vibration. If the investigator still perceives the vibration as soon as the patient says he does not feel the vibration, it is considered neuropathy. a day before the start of treatment
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05666479 - CGM Monitoring in T2DM Patients Undergoing Orthopaedic Replacement Surgery
Completed NCT05647083 - The Effect of Massage on Diabetic Parameters N/A
Active, not recruiting NCT05661799 - Persistence of Physical Activity in People With Type 2 Diabetes Over Time. N/A
Completed NCT03686722 - Effect of Co-administration of Metformin and Daclatasvir on the Pharmacokinetis and Pharmacodynamics of Metformin Phase 1
Completed NCT02836704 - Comparison of Standard vs Higher Starting Dose of Insulin Glargine in Chinese Patients With Type 2 Diabetes (Glargine Starting Dose) Phase 4
Completed NCT01819129 - Efficacy and Safety of FIAsp Compared to Insulin Aspart in Combination With Insulin Glargine and Metformin in Adults With Type 2 Diabetes Phase 3
Completed NCT04562714 - Impact of Flash Glucose Monitoring in People With Type 2 Diabetes Using Non-Insulin Antihyperglycemic Therapy N/A
Completed NCT02009488 - Treatment Differences Between Canagliflozin and Placebo in Insulin Secretion in Subjects With Type 2 Diabetes Mellitus (T2DM) Phase 1
Completed NCT05896319 - Hyaluronic Acid Treatment of the Post-extraction Tooth Socket Healing in Subjects With Diabetes Mellitus Type 2 N/A
Recruiting NCT05598203 - Effect of Nutrition Education Groups in the Treatment of Patients With Type 2 Diabetes N/A
Completed NCT05046873 - A Research Study Looking Into Blood Levels of Semaglutide and NNC0480-0389 When Given in the Same Injection or in Two Separate Injections in Healthy People Phase 1
Terminated NCT04090242 - Impact of App Based Diabetes Training Program in Conjunction With the BD Nano Pen Needle in People With T2 Diabetes N/A
Completed NCT04030091 - Pulsatile Insulin Infusion Therapy in Patients With Type 1 and Type 2 Diabetes Mellitus Phase 4
Completed NCT03604224 - A Study to Observe Clinical Effectiveness of Canagliflozin 300 mg Containing Treatment Regimens in Indian Type 2 Diabetes Participants With BMI>25 kg/m^2, in Real World Clinical Setting
Completed NCT03620357 - Continuous Glucose Monitoring & Management In Type 2 Diabetes (T2D) N/A
Completed NCT01696266 - An International Survey on Hypoglycaemia Among Insulin-treated Patients With Diabetes
Completed NCT03620890 - Detemir Versus NPH for Type 2 Diabetes Mellitus in Pregnancy Phase 4
Withdrawn NCT05473286 - A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Germany, as Part of Local Clinical Practice
Not yet recruiting NCT05029804 - Effect of Walking Exercise Training on Adherence to Disease Management and Metabolic Control in Diabetes N/A
Completed NCT04531631 - Effects of Dorzagliatin on 1st Phase Insulin and Beta-cell Glucose Sensitivity in T2D and Monogenic Diabetes Phase 2